[Guillain-Barré syndrome in kidney transplant].
García Alvarez
T
T
García Herrera
A
A
Mazuecos Blanca
A
A
Lancho Novillo
C
C
D003131:Combined Modality Therapy; D003586:Cytomegalovirus Infections / Q000150:complications*; D005260:Female; D020275:Guillain-Barre Syndrome / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D010243:Paralysis / Q000209:etiology; D010956:Plasmapheresis; D011183:Postoperative Complications / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000209:etiology* / Q000628:therapy; D055815:Young Adult
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents